Unitedhealth Group Inc header image

Unitedhealth Group Inc

UNH

Equity

ISIN null / Valor 1078451

New York Stock Exchange, Inc (2025-11-21)
USD 319.97+2.71%

Unitedhealth Group Inc
UMushroom community rating:

star star star star star
3.50 64 votes No rating yet
NegativeNeutralPositive

About company

UnitedHealth Group Inc. is a diversified health care company, operating through its two main subsidiaries, Optum and UnitedHealthcare, to foster a modern, efficient health system. Optum focuses on improving health care delivery through technology and data, providing tools and support to enhance the health of individuals and communities. UnitedHealthcare, on the other hand, offers a comprehensive range of health benefits, including affordable coverage and access to quality care, aimed at simplifying the health care experience for consumers. UnitedHealth Group is committed to serving the health care needs of over 152 million people worldwide, promoting a value-based care system that emphasizes compassionate and equitable treatment. The company's efforts are geared towards making high-quality care both affordable and accessible, leveraging cross-sector collaboration and technological innovation to meet consumer needs and improve the overall health care landscape.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (20.10.2025):

UnitedHealth Group Inc. reported its second quarter of 2025 results and has updated its 2025 financial outlook. The company has revised its revenue and earnings projections, reflecting strong first-half performance and anticipated care trends, with expectations to return to earnings growth in 2026.

Updated 2025 Financial Outlook

UnitedHealth Group Inc. has revised its 2025 revenue forecast to between $445.5 billion and $448.0 billion. The company now projects net earnings of at least $14.65 per share and adjusted earnings of at least $16.00 per share, reflecting improved performance in the first half of the year and optimistic expectations for the remainder of 2025.

Focus on Operational Excellence

CEO Stephen Hemsley emphasized the company's commitment to strengthening operating disciplines to support growth beyond 2026. UnitedHealth Group is dedicated to serving millions of patients, physicians, and customers, underpinned by a culture of service and long-standing values.

Future Growth Prospects

The company anticipates a return to earnings growth in 2026, driven by higher realized and anticipated care trends. UnitedHealth Group remains focused on positioning itself for sustained performance and expansion in the healthcare sector.

Upcoming Investor Communication

UnitedHealth Group will provide additional details regarding its current and planned actions in a teleconference for analysts and investors scheduled for today at 8 a.m. ET.

Summarized from source with an LLMView Source

Key figures

-46.4%1Y
-38.1%3Y
-4.40%5Y

Performance

51.0%1Y
34.9%3Y
30.3%5Y

Volatility

Market cap

289841 M

Market cap (USD)

Daily traded volume (Shares)

8,406,306

Daily traded volume (Shares)

1 day high/low

509.71 / 500.7

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.50

64 votes
Performance:
starstarstarstarstar
3.28
Innovation:
starstarstarstarstar
3.14
Society:
starstarstarstarstar
3.34
Nature:
starstarstarstarstar
3.25
Steven Tan
United Kingdom, 13 Nov 2025
star star star star star
undervalued, good set up for 2026
Harry Root
United Kingdom, 12 Nov 2025
star star star star star
Due for a rise
Matthew Doel
United Kingdom, 09 Nov 2025
star star star star star
Undervalued

EQUITIES OF THE SAME SECTOR

Dyne Therapeutics Inc
Dyne Therapeutics Inc Dyne Therapeutics Inc Valor: 56806425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.27%USD 21.18
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.95%EUR 26.60
Bright Horizons Family Solutions
Bright Horizons Family Solutions Bright Horizons Family Solutions Valor: 19920287
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.62%USD 101.12
Dr Reddy'S Laboratories Ltd
Dr Reddy'S Laboratories Ltd Dr Reddy'S Laboratories Ltd Valor: 1221723
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 13.91
COSMO Pharmaceuticals N.V.
COSMO Pharmaceuticals N.V. COSMO Pharmaceuticals N.V. Valor: 32590356
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.45%CHF 67.10
SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA SCHOTT Pharma AG & Co. KGaA Valor: 128964250
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.66%EUR 18.44
Coloplast A/S
Coloplast A/S Coloplast A/S Valor: 20259063
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.55%DKK 580.20
MannKind Corp
MannKind Corp MannKind Corp Valor: 35935511
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.21%USD 5.03
Essity AB
Essity AB Essity AB Valor: 36851944
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.79%SEK 260.90
Lifco Ab
Lifco Ab Lifco Ab Valor: 111355378
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.18%SEK 342.20